glp 1 and atrial fibrillation For patients with obesity fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 Mechanisms of GLP-1 Receptor Agonists

Increase intake of sulphur-rich cruciferous and allium vegetables Aim for 150-300 minutes of moderate physical activity weekly Prioritise 7-9 hours of quality sleep nightly Implement stress management practices such as mindfulness or meditation Minimise or eliminate alcohol to preserve glutathione for liver protection Combining Glutathione with Other Liver Support Supplements Many people with fatty liver choose to take multiple supplements as part of a comprehensive liver support strategy

Another proposed mechanism involves the inhibition of the transcriptional activity of nuclear factor erythroid 2-related factor 2, a key regulator of antioxidant defense systems, by elevated levels of homocysteine

Researchers have also noted that 70% of diabetes patients discontinue GLP-1 receptor agonist treatment within two years, limiting the long-term efficacy of these drugs

Retrieved 20 November 2019